Skip to main content
. 2019 Apr 29;173(6):534–543. doi: 10.1001/jamapediatrics.2019.0800

Table 2. Repeated Measures Outcomes Analyzed Using Generalized Linear Mixed Model Analysis.

Variable P Value Estimate (95% CI)a
Residual Group No Residual Group
Weekly feedings, mL/kg/d
Birth weight .03 NA NA
GA <.001 NA NA
GA × week <.001 NA NA
Week .006 NA NA
Treatment .048 NA NA
Treatment × week .02 NA NA
Simple main effects
Week 1 .27 25.7 (21.8 to 29.5) 22.6 (18.6 to 26.5)
Week 2 .12 83.2 (72.9 to 93.4) 94.7 (84.3 to 105.2)
Week 3 .28 109.2 (98.5 to 120.0) 117.7 (106.9 to 128.5)
Week 4 .15 119.4 (109.5 to 129.4) 129.6 (119.7 to 139.6)
Week 5 .03 123.9 (115.2 to 132.6) 137.2 (128.6 to 145.8)
Week 6 .03 128.4 (119.9 to 136.9) 141.6 (133.2 to 150.0)
Estimated log direct bilirubin
Week <.001 NA NA
GA <.001 NA NA
Birth weight <.001 NA NA
Treatment
Transformed values .98 −0.777 (−0.892 to −0.661) −0.778 (−0.895 to −0.661)
Untransformed valuesb NA 0.690 (0.563 to 0.819)b 0.671 (0.542 to 0.799)b
Occurrence of elevated (>2 mg/dL) direct bilirubin
GA .07 NA NA
Birth weight .008 NA NA
Treatment .53 0.040 (0.017 to 0.092) 0.057 (0.025 to 0.131)
Estimated log transformed weight
Birth weight <.001 NA NA
GA <.001 NA NA
Week <.001 NA NA
GA × treatment .047 NA NA
Treatment
Transformed values .03 6.98 (6.97 to 7.00) 7.01 (6.99 to 7.02)
Untransformed valuesb NA 1129.7 (1111 to 1148)b 1145.3 (1126 to 1164)b
Head circumference
Week .02 NA NA
Birth HC <.001 NA NA
GA <.001 NA NA
Birth HC × week <.001 NA NA
GA × week <.001 NA NA
Treatment .56 25.94 (25.71 to 26.17) 25.85 (25.62 to 26.08)
Length
Birth length <.001 NA NA
GA <.001 NA NA
Week <.001 NA NA
Birth length × treatment .008 NA NA
GA × treatment .005 NA NA
Treatment .59 36.41 (36.08 to 36.74) 36.78 (36.44 to 37.11)

Abbreviations: GA, gestational age; HC, head circumference; NA, not applicable.

a

All estimates are least square means except for occurrence of elevated bilirubin, which are odds.

b

Untransformed values provided for clinical reference only.